EUVIMEDEUVIMED entdecken
Crossref

Diosmin alleviates NLRP3 inflammasome-dependent cellular pyroptosis after stroke through RSK2/CREB pathway

Yanfei Lu, Min Shi, Wei Huang, Fenfen Li, Haowei Liang, Wenbing Liu, Tianyi Huang, Zhen Xu

Brain Research · 2025

DOI: 10.1016/j.brainres.2024.149336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2025. Verfasst von Yanfei Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Zhejiang Rehabilitation Medical Center (Rehabilitation Hospital Affiliated to Zhejiang Chinese Medical University), China. Hauptthemen laut MEDLINE: Pyroptosis, NLR Family, Pyrin Domain-Containing 3 Protein, Ribosomal Protein S6 Kinases, 90-kDa, Inflammasomes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the context of our previous analyses on the main active ingredients of Jieyudan, a classic formula targeting aphasia in stroke, we further delve into the function and mechanisms of its active ingredient, Diosmin (DM), which may exert neuroprotective effects, in ischemic stroke. Herein, bioinformatics analysis revealed targets of DM and their intersection with differentially expressed genes in ischemic stroke. Middle cerebral artery occlusion (MCAO) rats and oxygen-glucose deprivation (OGD) cells were used to construct in vivo and in vitro models of ischemic stroke. The effects of DM on MCAO rats were assessed by Zea-Longa score, Morris water maze, TTC staining, Nissl staining, immunohistochemistry, and Western blot. At the cellular level, cell counting kit-8 assay and Western blot were carried out to verify the mechanism of DM in ischemic stroke. In vivo, DM decreased neurological deficit score, cerebral infarct volume and neuronal damage, and improved cognitive function in MCAO rats. In vitro, DM increased the viability of OGD-treated cells. In addition, DM down-regulated the expressions of NLR family pyrin domain containing 3 (NLRP3) and pyroptosis-associated proteins, while up-regulating ribosomal protein S6 kinase A3 (RSK2) level and activating cyclic-AMP response element-binding protein (CREB) signaling. Conversely, RSK2 inhibitor LJH685 reduced the viability and promoted pyroptosis-associated protein levels, which also partially reversed the effects of DM in vitro. Collectively, DM plays a therapeutic role in ischemic stroke by inhibiting NLRP3 inflammasome-mediated cellular pyroptosis via the RSK2/CREB pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisNLR Family, Pyrin Domain-Containing 3 ProteinRibosomal Protein S6 Kinases, 90-kDaInflammasomesRats, Sprague-DawleySignal TransductionNeuroprotective AgentsDiosminCyclic AMP Response Element-Binding ProteinStrokeAnimalsRatsMaleInfarction, Middle Cerebral ArteryBrain Ischemia

Stichwörter der Autor:innen

DiosminIschemic strokePyroptosisRibosomal protein S6 kinase A3-CREB pathway

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinRibosomal Protein S6 Kinases, 90-kDaInflammasomesNlrp3 protein, ratribosomal protein S6 kinase, 90kDa, polypeptide 3Neuroprotective AgentsDiosminCyclic AMP Response Element-Binding ProteinCreb1 protein, rat

Autor:innen und Institutionen

  • Department of Pharmacy, Zhejiang Rehabilitation Medical Center (Rehabilitation Hospital Affiliated to Zhejiang Chinese Medical University), China.
  • Department of Pharmacy, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincal Hospital of Traditional Chinese Medicine), China.
  • College of Pharmacy, Zhejiang Chinese Medical University, China.
  • Graduate School of Zhejiang Chinese Medical University, China.
  • Department of Cardiopulmonary Rehabilitation, the Third Affiliated Hospital of Zhejiang Chinese Medical University, China.
  • Department of Pharmacy, Affiliated Xiaoshan Hospital, Hangzhou Normal University, China. Electronic address: xuzhenxsyy@126.com.

Zitieren

APA

Lu, Y., Shi, M., Huang, W., Li, F., Liang, H., Liu, W., Huang, T., & Xu, Z. (2025). Diosmin alleviates NLRP3 inflammasome-dependent cellular pyroptosis after stroke through RSK2/CREB pathway. Brain Research. https://doi.org/10.1016/j.brainres.2024.149336

Vancouver

Lu Y, Shi M, Huang W, Li F, Liang H, Liu W, et al. Diosmin alleviates NLRP3 inflammasome-dependent cellular pyroptosis after stroke through RSK2/CREB pathway. Brain Research. 2025. doi:10.1016/j.brainres.2024.149336

BibTeX
@article{Lu2025,
  author = {Lu, Yanfei and Shi, Min and Huang, Wei and Li, Fenfen and Liang, Haowei and Liu, Wenbing and Huang, Tianyi and Xu, Zhen},
  title = {Diosmin alleviates NLRP3 inflammasome-dependent cellular pyroptosis after stroke through RSK2/CREB pathway},
  journal = {Brain Research},
  year = {2025},
  doi = {10.1016/j.brainres.2024.149336}
}
Kostenlos starten →